Ferritin Nanocaged Doxorubicin Potentiates Chemo‐Immunotherapy against Hepatocellular Carcinoma via Immunogenic Cell Death

Author:

Chen Yang12,Zeng Linyuan34,Zhu Hongzhang3,Wu Qifei56,Liu Rong1,Liang Qian5,Chen Bin3,Dai Haitao3,Tang Keyu3,Liao Changli3,Huang Yonghui3,Yan Xiyun5,Fan Kelong5,Du Jin‐Zhi1,Lin Run34,Wang Jun7ORCID

Affiliation:

1. School of Medicine South China University of Technology Guangzhou Guangdong 510006 China

2. Department of Clinical Laboratory The First Affiliated Hospital of Nanchang University Nanchang Jiangxi 330006 China

3. Department of Radiology The First Affiliated Hospital Sun Yat‐sen University Guangzhou Guangdong 510080 China

4. Center for Precision Medicine Sun Yat‐sen University Guangzhou Guangdong 510080 China

5. CAS Engineering Laboratory for Nanozyme Key Laboratory of Protein and Peptide Pharmaceuticals Institute of Biophysics Chinese Academy of Sciences Beijing 100101 China

6. Department of Thoracic Surgery The First Affiliated Hospital of Xi'an Jiaotong University Xi'an Shaanxi Province 710061 China

7. School of Biomedical Sciences and Engineering South China University of Technology Guangzhou International Campus Guangzhou Guangdong 511442 China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

General Materials Science,General Chemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3